Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

UNITEDHEALTH GROUP (UNH)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.
  • UnitedHealth Group accounts for 5.13 % of our USA Portfolio. A trade is currently open since 11/02/2015 with a purchase price of $ 119.36. Discover the other 19 stocks of the USA portfolio managed by the 4-traders portfolio management team.
Strengths
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • Historically, the company has been releasing figures that are above expectations.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The tendency within the weekly time frame is positive above the technical support level at 192.52 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 226.78.
  • Technically, the stock approaches a strong medium-term resistance at USD 228.17.
Ratings chart
Sector Managed Healthcare - NEC
1st jan.Capitalisation (M$)Investor Rating
UNITEDHEALTH GROUP38.25%214 469
AETNA INC44.43%58 600
ANTHEM INC57.97%58 082
CIGNA CORPORATION55.87%50 331
HUMANA INC25.59%36 235
CENTENE CORP79.07%16 370
WELLCARE HEALTH PLANS, INC.51.25%8 978
MOLINA HEALTHCARE, INC.38.39%4 355
MAGELLAN HEALTH INC28.84%2 303
More Results
Financials ($)
Sales 2017 201 B
EBIT 2017 15 396 M
Net income 2017 9 251 M
Debt 2017 15 170 M
Yield 2017 1,13%
P/E ratio 2017 23,54
P/E ratio 2018 21,60
EV / Sales 2017 1,14x
EV / Sales 2018 1,01x
Capitalization 214 B
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart UNITEDHEALTH GROUP
Duration : Period : Day
UnitedHealth Group Technical Analysis Chart | UNH | US91324P1021 | 4-Traders
Duration : Period : Week
UnitedHealth Group Technical Analysis Chart | UNH | US91324P1021 | 4-Traders